Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/110769
dc.contributor.author | Chaccour, Carlos |
---|---|
dc.contributor.author | Rabinovich, Regina |
dc.date | 2017-05-10T13:26:31Z |
dc.date | 2017-05-10T13:26:31Z |
dc.date | 2017-04-24 |
dc.date | 2017-05-03T18:01:50Z |
dc.identifier.citation | 1475-2875 |
dc.identifier.uri | http://hdl.handle.net/2445/110769 |
dc.format | 13 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Biomed Central |
dc.relation | Reproducció del document publicat a: http://dx.doi.org/10.1186/s12936-017-1802-3 |
dc.relation | Malaria Journal, 2017, vol. 16, num. 1, p. 166 |
dc.relation | http://dx.doi.org/10.1186/s12936-017-1802-3 |
dc.rights | cc by (c) Chaccour et al., 2017 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | http://creativecommons.org/licenses/by/3.0/es/ |
dc.subject | Malària |
dc.subject | Assaigs clínics |
dc.subject | Malaria |
dc.subject | Clinical trials |
dc.title | Ivermectin to reduce malaria transmission II. Considerations regarding clinical development pathway |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |